Ellis Investment Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ellis Investment Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25	Closed	-$5K	–	807
2021 Q1	$5K	Hold	25	–	–	﹤0.01%	672
2020 Q4	$3K	Hold	25	–	–	﹤0.01%	675
2020 Q3	$2K	Hold	25	–	–	﹤0.01%	686
2020 Q2	$3K	Hold	25	–	–	﹤0.01%	661
2020 Q1	$2K	Hold	25	–	–	﹤0.01%	663
2019 Q4	$2K	Buy	+25	New	+$2.8K	﹤0.01%	654

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Ellis Investment Partners's GWPH Position: Q2 2021 in Review

Ellis Investment Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 25 shares — an estimated $5K sold.

Ellis Investment Partners first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $5K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Ellis Investment Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Ellis Investment Partners sold 25 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $5K.
Ellis Investment Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
Ellis Investment Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Ellis Investment Partners's 13F filing for Q2 2021, filed 26 Jul 2021.